Evidence-Based Management of MASLD: GRADE Evaluation of Pharmacological Therapies. [PDF]
Karavia EA +7 more
europepmc +1 more source
Nephroprotective and antioxidant properties of a novel herbal extract combination in a high-fat diet and alloxan-induced kidney injury in rats. [PDF]
Yulizal OK +5 more
europepmc +1 more source
Peroxisome Proliferator-Activated Receptors (PPARs) in Psoriasis: Metabolic Intersections, Molecular Mechanisms, and Potential Treatments. [PDF]
Pinnelli VBK +10 more
europepmc +1 more source
Glucosylceramide regulates depression through activating peroxisome proliferator-activated receptor gamma in dorsal striatum. [PDF]
Jiang L +22 more
europepmc +1 more source
Cost effectiveness analysis of six non insulin agents for type 2 diabetes in Iran using a patient level simulation with UKPDS OM2. [PDF]
Darvishi A +4 more
europepmc +1 more source
Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes. [PDF]
Malandris K +3 more
europepmc +1 more source
Reversal of diabetes-associated cognitive impairment through modulation of BDNF, insulin, and NF-κB pathways by a marketed herbal formulation. [PDF]
Kinattingal N +5 more
europepmc +1 more source
Targeting the PPAR-γ/OPTN axis to inhibit apoptosis in steroid-induced glaucoma. [PDF]
Liang X, Li N, Gong Q, Wang H.
europepmc +1 more source
Antidiabetes agents and risk of incident depression in 686,522 people with type 2 diabetes mellitus: A 20-year population-based cohort study. [PDF]
Ho MTH +9 more
europepmc +1 more source

